The full impact of APOE4 (apolipoprotein E4), the strongest genetic risk factor for Alzheimer's disease (AD), on neuronal and network function remains unclear, particularly during early preclinical stages of disease. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.